glp-1 obesity drug news today october 23 2025 RA Weight Loss Drugs May Carry Untold Ocular Burden GLP-1 Agonists Weight Loss Drugs

demonstrated that GLP-1 agonist administration could lead to an increase in neurogenesis in the hippocampus dentate gyrus region, and demonstrated an improvement in mood and cognitive function through the swim test in adult rodents (Isacson et al., 2011)

10.3390/ijms20071584 11 ChouC

J Headache Pain 26 , 202 (2025)

Alzheimer's disease (AD) is characterized by neurodegeneration of cholinergic neurons in the hippocampus

Cultures were 8595% confluent on the day of the experiment

However, some scholars have proposed that the effect of GLP-1 in the liver is indirectly mediated by multiple mechanisms, such as reducing fat absorption or inhibiting fat cells through acyl-CoA synthetase long chain family member 1 (ACSL1), CCAAT/enhancer binding protein (C/EBP), peroxisome proliferator-activated receptor- (PPAR), and sterol regulatory element binding protein-1c (SREBP-1c) pathways to achieve the purpose of reducing liver lipids [38]